RAP 0.00% 20.5¢ resapp health limited

Ann: Morgans Initiates Research Coverage, page-6

  1. 42 Posts.
    The target price is based on discounted cash flow method which they have included in the report. The revenue figures look very low to me - just under $30m total revenue for all years up to June 30 2020.

    If revenues are (as I would expect) significantly higher than that, obviously their target price will be off.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.